Precision BioSciences logo
Precision BioSciences DTIL
$ 4.75 3.26%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Precision BioSciences Financial Statements 2011-2024 | DTIL

Annual Financial Statements Precision BioSciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

49.9 M 3.16 M 249 M 634 M 349 M - - - - - - - -

Shares

3.84 M 2.93 M 58.7 M 52.3 M 42 M - - - - - - - -

Historical Prices

13 1.08 4.25 12 8.01 - - - - - - - -

Net Income

-61.3 M -112 M -30.6 M -109 M -92.9 M -46 M -21.1 M - - - - - -

Revenue

48.7 M 25.1 M 116 M 24.3 M 22.2 M 10.9 M 6.48 M - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - 24.3 M - - - - - - - - -

Operating Income

-43.7 M -62.3 M -39.4 M -110 M -87.2 M -47.9 M - - - - - - -

Interest Expense

2.23 M 1.11 M 132 K 822 K 182 K 1.88 M - - - - - - -

EBITDA

-36.9 M -54.5 M -30.4 M -100 M -81.9 M -45.6 M -20.4 M - - - - - -

Operating Expenses

92.5 M 87.4 M 155 M 134 M 109 M - - - - - - - -

General and Administrative Expenses

39.1 M 41.3 M 39.7 M 36.1 M 27 M 13.7 M 8.02 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Precision BioSciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

7.29 M 6.97 M 5.06 M 4.16 M 3.84 M 3.8 M 3.71 M 111 M 111 M 68 M 61 M 60.9 M 59.7 M 57.7 M 56.6 M 52.7 M 52.3 M 51.9 M 51.3 M 51.2 M 50.6 M 50 M 16 M 15.9 M 15.8 M 15.7 M 15.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-16.4 M 32.7 M 8.59 M - -8.08 M -11.9 M -25.1 M - -23.9 M -31 M -28.2 M - -11.3 M 21.7 M -18.7 M - -26 M -32.7 M -26.8 M - -20.7 M -19.4 M -31.8 M - -9.76 M -11.8 M -9.01 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

576 K 49.9 M 17.6 M - 13.1 M 19.8 M 8.78 M - 7.36 M 3.82 M 3.32 M - 24 M 68.8 M 16.3 M - 7.36 M 1.08 M 7 M - 4.86 M 5.39 M 5.46 M - 2.54 M 1.87 M 1.53 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-21.3 M 24.1 M -4.19 M - -12.4 M -3.13 M -13.4 M - -14.7 M -29.6 M -27.3 M - -11.5 M 21.6 M -18.7 M - -26 M -32.8 M -27.5 M - -22 M -23.9 M -19.5 M - -10.4 M -12.1 M -9.24 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

256 K 560 K 574 K - 576 K 553 K 522 K - 405 K 178 K 42 K - 55 K 24 K 53 K - 28 K 107 K 660 K - 182 K 182 K 182 K - 691 K 299 K 223 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -3.04 M - - - -11.4 M - -8.84 M -25.7 M -25.4 M - -4.74 M 26.2 M -16.6 M - -19.5 M -28.4 M -25.3 M - -18.5 M -21.8 M -18.6 M - -8.89 M -11.2 M -8.78 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

21.9 M 25.8 M 21.8 M - 25.5 M 22.9 M 22.1 M - 22 M 33.4 M 30.7 M - 35.6 M 47.2 M 35.1 M - 33.4 M 33.9 M 34.5 M - 26.8 M 29.3 M 25 M - 13 M 14 M 10.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

8.77 M 8.53 M 8.43 M - 9.63 M 9.83 M 11.1 M - 10.3 M 10.4 M 10.7 M - 9.64 M 9.94 M 9.5 M - 8.53 M 8.7 M 9.62 M - 7.05 M 6.5 M 5 M - 3.25 M 3.13 M 2.65 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency